Cannabis Therapy Corp. (CTCO) 0.1820 $CTCO
North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020
M2 - Mon Sep 14, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n7wcc2/north_america) has announced the addition of the "North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020" report to their offering. The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others. Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader: - The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp - The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized - Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014) - The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others - Through the forecast period, the other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana - The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity - The report includes the estimates of different entities of the cannabis ecosystem - The report also includes the optimistic revenue estimate for the benchmark year only for the U.S - Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included Key Topics Covered: 1 Research Methodology, Scope And Coverage 2 Executive Summary 3 Introduction To North American Cannabis Market 4 Key Strategies And Development In The North American Cannabis Market (2013-2015) 5 Market Dynamics 6 North America Cannabis Industry Analysis 7 Regulatory & Legal Framework, Consortiums And Compliances 8 Market Sizing - Estimation, Analysis & Forecast By Derivative 9 Market Sizing- Estimation, Analysis & Forecast By Application 10 Market Sizing Analysis & Forecast, By Market Demand 11 Key Market Players Profiles - 22nd Century Group, Inc. - Abattis Bioceuticals Corporation - Advanced Cannabis Solutions - Affinor Growers - Agrisoft Development Group - Arena Pharmaceuticals, Inc. - Canadian Cannabis Corporation - Canna Brands Inc. - Canna Grow Holdings - Cannabics Pharmaceuticals Inc. - Cannabis Sativa Inc. - Cannabis Science, Inc. - Cannabis Therapy Corporation - Cannacare Docs - Cannavest - Dave - Eaze - Endexx Corporation - Equipment & Infrastructure - Frweed Pro - Grassp - Green Technology Solutions Inc. (Gtso) - Gw Pharmaceuticals - Hemp, Inc. - Information Technology - Insys Therapeutics - Leafly - Mass Roots - Meadow - Medbox, Inc. - Medical Marijuana Inc. - Nestdrop - Omnicanna Health Solutions - Otsuka Pharmaceutical Co. Ltd - Plandai Biotechnology - Privateer Holdings, Inc. - Quantum 9 - Sanofi Pharmaceuticals - Surna, Inc. - Tweed Marijuana Inc. - Weedmaps For more information visit http://www.researchandmarkets.com/research/n7...th_america
XXII: 1.08 (unch), INSY: 25.65 (+0.64), ARNA: 2.19 (+0.14)
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 87.75 (+0.45), FULL: 3.10 (+0.01), CARA: 14.40 (-0.18), ICN: 21.17 (+0.01)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 87.75 (+0.45), FULL: 3.10 (+0.01), CARA: 14.40 (-0.18)
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 87.75 (+0.45), DE: 79.87 (-1.04), FULL: 3.10 (+0.01), CARA: 14.40 (-0.18)
CannabisFN: What to Watch in the Week Ahead
ACCESSWIRE - Tue Jan 20, 1:00PM CST
WHITEFISH, MT / ACCESSWIRE / January 20, 2015 / The cannabis industry began the new year on a high note, with the Marijuana Index(TM) rebounding off of its 52-week lows established on December 31, 2014. With Peter Thiel's big decision to invest in the pot industry and favorable new legislation being introduced, investors' appetite for marijuana stocks could be on the rise in 2015 after a rough end to 2014. The venture market for weed stocks has also been on the rise, which suggests that some big-name initial public offerings could be on the way as the industry matures.
MGW.VN: 0.045 (unch)
This Is Where The Investment Opportunity Is Right Now In Cannabis
Small Cap Reporter - at Seeking Alpha - Tue Jan 20, 11:25AM CST
INSY: 25.65 (+0.64), GWPH: 87.75 (+0.45)
Peak Pharmaceuticals Is Pleased to Announce Strong Order Volume for Its Canna-Pet Products
Marketwired - Thu Jan 15, 7:55AM CST
Peak Pharmaceuticals, Inc. (OTCQB: CTCO) ("Peak Pharma" or the "Company"
, a growth stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, hemp-based, medicinal therapies and supplements (Nutraceuticals) for both humans and animals is pleased to advise of recent corporate achievements.
PEAK Pharmaceuticals Lays Out Plan to Drive Value in 2015
ACCESSWIRE - Wed Jan 14, 8:45AM CST
WHITEFISH, MT / ACCESSWIRE / January 14, 2015 / PEAK Pharmaceuticals Inc. (OTC: CTCO) has made tremendous strides over the past year targeting the biotechnology side of the cannabis industry. After signing a worldwide license agreement with Canna-Pet LLC and a cultivation agreement with a Colorado-based hemp farm, the company changed its name from Cannabis Therapy Corp. to PEAK Pharmaceuticals, Inc. to better reflect its focus on development and sales of pharmaceutical grade, hemp-based medicinal products for humans and pets.
GWPH: 87.75 (+0.45), WOOF: 55.92 (+0.89), PETM: 82.98 (+0.03)
Peak Pharmaceuticals, Inc. Announces Name Change From Cannabis Therapy Corp.
Marketwired - Tue Jan 13, 7:58AM CST
Peak Pharmaceuticals, Inc. (OTCQB: CTCO), formerly Cannabis Therapy Corp. (the "Company" , a growth stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, hemp-based medicinal therapies and supplements (Nutraceuticals), wishes to advise that on December 23, 2014, Cannabis Therapy Corp., a Nevada corporation, entered into an Agreement and Plan of Merger pursuant to which the shareholders of the Company became shareholders of the surviving company named Peak Pharmaceuticals, Inc., a Nevada corporation.
Cannabis Therapy Corp. to Present at SeeThruEquity MicroCap Investor Forum November 12th in NYC
Marketwired - Fri Nov 07, 8:01AM CST
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" , a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), today announced that Company CEO Dr. Soren Mogelsvang PhD and CFO Mr. Arnold Tinter will be presenting at SeeThruEquity's upcoming fall 2014 Microcap Investor Conference, being held at New York City's Convene Midtown East on November 12, 2014 at 10:00 A.M. Eastern.
Cannabis Stocks Regain Ground Last Week Ahead of Elections
ACCESSWIRE - Mon Oct 27, 9:00AM CDT
Whitefish, MT / ACCESSWIRE / October 27, 2014 / Cannabis stocks gained ground last week, led by a ~15% recovery in shares of GW Pharmaceuticals plc (NASDAQ: GWPH). MedBox Inc. (OTC: MDBX) shares also rose more than 25%, sending the overall Marijuana Index(TM) significantly higher for the week. Traders will be watching for a continuation of these trends into this week, although a lot may depend on the movements of the larger overall market.
GWPH: 87.75 (+0.45)
Cannabis Therapy Gears Up Canna-Pet Business
ACCESSWIRE - Thu Oct 23, 8:05AM CDT
WHITEFISH, MT / October 23, 2014 / The widespread legalization of medical cannabis may be helping mankind deal with many unmet medical needs, but man's best friend has been largely ignored.
PETS: 16.44 (-0.04), WOOF: 55.92 (+0.89), PETM: 82.98 (+0.03)
Cannabis Therapy Corp. Announces Revenue Milestone With Launch of Updated Canna-Pet(TM) Website
Marketwired - Wed Oct 22, 8:07AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" , a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, ultra-low THC, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is extremely pleased to announce the launch of its all-new Canna-Pet(TM) commercial website (www.canna-pet.com).
Neutra Corp Doubles but Cannabis Stocks Move Largely Lower Last Week
ACCESSWIRE - Mon Oct 06, 8:06AM CDT
Whitefish, MT / Oct 6, 2014 / Cannabis industry stocks moved lower last week, according to the Marijuana Index(tm). Top gainers included Neutra Corp. (OTC: NTRR), which soared more than 100%, after its joint venture partner Vertigo Technologies acquired Contain a Grow. Industry bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) also moved higher later in the week after it was upgraded by Zacks from Neutral to Outperform.
INSY: 25.65 (+0.64), GWPH: 87.75 (+0.45)
Cannabis Therapy's Hemp Harvest Paves Way to Commercialization
ACCESSWIRE - Tue Sep 30, 8:58AM CDT
WHITEFISH, MT / September 30, 2014 / Through an agreement with Rocky Mountain Hemp Inc., a relatively known micro-cap cannabis company will produce the first U.S.-grown hemp used in a commercial product in over 60 years. The low-THC and CBD-rich hemp will be used to support near-term commercial endeavors.
GWPH: 87.75 (+0.45)
Cannabis Therapy Corp. Harvests Its First Colorado Hemp Crop
Marketwire - Mon Sep 29, 8:02AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" , a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, ultra-low THC, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased to announce it recently passed pre-harvest inspection by the Colorado Department of Agriculture, and subsequently harvested its first ever hemp crop which is now slated for near term product development and commercial applications.
North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020
M2 - Mon Sep 14, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n7wcc2/north_america) has announced the addition of the "North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020" report to their offering. The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others. Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader: - The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp - The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized - Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014) - The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others - Through the forecast period, the other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana - The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity - The report includes the estimates of different entities of the cannabis ecosystem - The report also includes the optimistic revenue estimate for the benchmark year only for the U.S - Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included Key Topics Covered: 1 Research Methodology, Scope And Coverage 2 Executive Summary 3 Introduction To North American Cannabis Market 4 Key Strategies And Development In The North American Cannabis Market (2013-2015) 5 Market Dynamics 6 North America Cannabis Industry Analysis 7 Regulatory & Legal Framework, Consortiums And Compliances 8 Market Sizing - Estimation, Analysis & Forecast By Derivative 9 Market Sizing- Estimation, Analysis & Forecast By Application 10 Market Sizing Analysis & Forecast, By Market Demand 11 Key Market Players Profiles - 22nd Century Group, Inc. - Abattis Bioceuticals Corporation - Advanced Cannabis Solutions - Affinor Growers - Agrisoft Development Group - Arena Pharmaceuticals, Inc. - Canadian Cannabis Corporation - Canna Brands Inc. - Canna Grow Holdings - Cannabics Pharmaceuticals Inc. - Cannabis Sativa Inc. - Cannabis Science, Inc. - Cannabis Therapy Corporation - Cannacare Docs - Cannavest - Dave - Eaze - Endexx Corporation - Equipment & Infrastructure - Frweed Pro - Grassp - Green Technology Solutions Inc. (Gtso) - Gw Pharmaceuticals - Hemp, Inc. - Information Technology - Insys Therapeutics - Leafly - Mass Roots - Meadow - Medbox, Inc. - Medical Marijuana Inc. - Nestdrop - Omnicanna Health Solutions - Otsuka Pharmaceutical Co. Ltd - Plandai Biotechnology - Privateer Holdings, Inc. - Quantum 9 - Sanofi Pharmaceuticals - Surna, Inc. - Tweed Marijuana Inc. - Weedmaps For more information visit http://www.researchandmarkets.com/research/n7...th_america
XXII: 1.08 (unch), INSY: 25.65 (+0.64), ARNA: 2.19 (+0.14)
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 87.75 (+0.45), FULL: 3.10 (+0.01), CARA: 14.40 (-0.18), ICN: 21.17 (+0.01)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 87.75 (+0.45), FULL: 3.10 (+0.01), CARA: 14.40 (-0.18)
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 87.75 (+0.45), DE: 79.87 (-1.04), FULL: 3.10 (+0.01), CARA: 14.40 (-0.18)
CannabisFN: What to Watch in the Week Ahead
ACCESSWIRE - Tue Jan 20, 1:00PM CST
WHITEFISH, MT / ACCESSWIRE / January 20, 2015 / The cannabis industry began the new year on a high note, with the Marijuana Index(TM) rebounding off of its 52-week lows established on December 31, 2014. With Peter Thiel's big decision to invest in the pot industry and favorable new legislation being introduced, investors' appetite for marijuana stocks could be on the rise in 2015 after a rough end to 2014. The venture market for weed stocks has also been on the rise, which suggests that some big-name initial public offerings could be on the way as the industry matures.
MGW.VN: 0.045 (unch)
This Is Where The Investment Opportunity Is Right Now In Cannabis
Small Cap Reporter - at Seeking Alpha - Tue Jan 20, 11:25AM CST
INSY: 25.65 (+0.64), GWPH: 87.75 (+0.45)
Peak Pharmaceuticals Is Pleased to Announce Strong Order Volume for Its Canna-Pet Products
Marketwired - Thu Jan 15, 7:55AM CST
Peak Pharmaceuticals, Inc. (OTCQB: CTCO) ("Peak Pharma" or the "Company"
, a growth stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, hemp-based, medicinal therapies and supplements (Nutraceuticals) for both humans and animals is pleased to advise of recent corporate achievements. PEAK Pharmaceuticals Lays Out Plan to Drive Value in 2015
ACCESSWIRE - Wed Jan 14, 8:45AM CST
WHITEFISH, MT / ACCESSWIRE / January 14, 2015 / PEAK Pharmaceuticals Inc. (OTC: CTCO) has made tremendous strides over the past year targeting the biotechnology side of the cannabis industry. After signing a worldwide license agreement with Canna-Pet LLC and a cultivation agreement with a Colorado-based hemp farm, the company changed its name from Cannabis Therapy Corp. to PEAK Pharmaceuticals, Inc. to better reflect its focus on development and sales of pharmaceutical grade, hemp-based medicinal products for humans and pets.
GWPH: 87.75 (+0.45), WOOF: 55.92 (+0.89), PETM: 82.98 (+0.03)
Peak Pharmaceuticals, Inc. Announces Name Change From Cannabis Therapy Corp.
Marketwired - Tue Jan 13, 7:58AM CST
Peak Pharmaceuticals, Inc. (OTCQB: CTCO), formerly Cannabis Therapy Corp. (the "Company"
, a growth stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, hemp-based medicinal therapies and supplements (Nutraceuticals), wishes to advise that on December 23, 2014, Cannabis Therapy Corp., a Nevada corporation, entered into an Agreement and Plan of Merger pursuant to which the shareholders of the Company became shareholders of the surviving company named Peak Pharmaceuticals, Inc., a Nevada corporation. Cannabis Therapy Corp. to Present at SeeThruEquity MicroCap Investor Forum November 12th in NYC
Marketwired - Fri Nov 07, 8:01AM CST
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
, a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), today announced that Company CEO Dr. Soren Mogelsvang PhD and CFO Mr. Arnold Tinter will be presenting at SeeThruEquity's upcoming fall 2014 Microcap Investor Conference, being held at New York City's Convene Midtown East on November 12, 2014 at 10:00 A.M. Eastern. Cannabis Stocks Regain Ground Last Week Ahead of Elections
ACCESSWIRE - Mon Oct 27, 9:00AM CDT
Whitefish, MT / ACCESSWIRE / October 27, 2014 / Cannabis stocks gained ground last week, led by a ~15% recovery in shares of GW Pharmaceuticals plc (NASDAQ: GWPH). MedBox Inc. (OTC: MDBX) shares also rose more than 25%, sending the overall Marijuana Index(TM) significantly higher for the week. Traders will be watching for a continuation of these trends into this week, although a lot may depend on the movements of the larger overall market.
GWPH: 87.75 (+0.45)
Cannabis Therapy Gears Up Canna-Pet Business
ACCESSWIRE - Thu Oct 23, 8:05AM CDT
WHITEFISH, MT / October 23, 2014 / The widespread legalization of medical cannabis may be helping mankind deal with many unmet medical needs, but man's best friend has been largely ignored.
PETS: 16.44 (-0.04), WOOF: 55.92 (+0.89), PETM: 82.98 (+0.03)
Cannabis Therapy Corp. Announces Revenue Milestone With Launch of Updated Canna-Pet(TM) Website
Marketwired - Wed Oct 22, 8:07AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
, a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, ultra-low THC, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is extremely pleased to announce the launch of its all-new Canna-Pet(TM) commercial website (www.canna-pet.com). Neutra Corp Doubles but Cannabis Stocks Move Largely Lower Last Week
ACCESSWIRE - Mon Oct 06, 8:06AM CDT
Whitefish, MT / Oct 6, 2014 / Cannabis industry stocks moved lower last week, according to the Marijuana Index(tm). Top gainers included Neutra Corp. (OTC: NTRR), which soared more than 100%, after its joint venture partner Vertigo Technologies acquired Contain a Grow. Industry bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) also moved higher later in the week after it was upgraded by Zacks from Neutral to Outperform.
INSY: 25.65 (+0.64), GWPH: 87.75 (+0.45)
Cannabis Therapy's Hemp Harvest Paves Way to Commercialization
ACCESSWIRE - Tue Sep 30, 8:58AM CDT
WHITEFISH, MT / September 30, 2014 / Through an agreement with Rocky Mountain Hemp Inc., a relatively known micro-cap cannabis company will produce the first U.S.-grown hemp used in a commercial product in over 60 years. The low-THC and CBD-rich hemp will be used to support near-term commercial endeavors.
GWPH: 87.75 (+0.45)
Cannabis Therapy Corp. Harvests Its First Colorado Hemp Crop
Marketwire - Mon Sep 29, 8:02AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
, a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, ultra-low THC, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased to announce it recently passed pre-harvest inspection by the Colorado Department of Agriculture, and subsequently harvested its first ever hemp crop which is now slated for near term product development and commercial applications. 
